Article
FDA Advisory Committee CMC Output — AdCom Intelligence Analysis
"When FDA convenes an advisory committee to examine how it evaluates CMC packages, it is signaling the direction of reviewer expectations before those expectations appear in final guidance…
XGene Articles & Analysis
Evidence-led analysis for decisions that matter.
Senior-authored regulatory, CMC, GMP, quality, and inspection analysis designed for practical use—not passive reading.
01SignalSource evidence
02InterpretTechnical judgment
03ApplyDecision pathway
Publication library
Keep moving from evidence to decision.
Article
FDA Advisory Committee CMC Output — AdCom Intelligence Analysis
"When FDA convenes an advisory committee to examine how it evaluates CMC packages, it is signaling the direction of reviewer expectations before those expectations appear in final guidance…
Article
Downstream Purification and Viral Clearance — ICH Q5A(R2) LRV Architecture
"Viral clearance data from scaled-down studies have not been provided for two of the chromatography steps — please provide the validation data or a scientific justification for omission."…
Article
EMA SPOR SMS — Substance Registration for EU CMC Submissions
Every EU marketing authorisation holder that has not registered its active substances in EMA's Substance Management Service is already experiencing submission delays and data reconciliation problems — and…
Article
Upstream Manufacturing Process — Bioreactor CPPs and the Biologics Process Section
An upstream bioreactor process description for a monoclonal antibody that specifies inoculation density, bioreactor volume, pH range, dissolved oxygen setpoint, and temperature — but does not address the…
Article
PQ-CMC Stability Structured Format — What FDA’s Parser Actually Reads
Stability data is the most data-rich component of any CMC submission — and the PQ-CMC structured format for stability data is designed to make that data machine-readable, cross-referenceable,…
Article
MCB-WCB Characterization — ICH Q5D Compliance and Cell Banking CMC
"Cell bank characterization data are incomplete — testing for adventitious viruses per the ICH Q5A(R2) panel has not been conducted at the MCB level." This deficiency, issued by…
Article
PQ-CMC Manufacturing Process 3.2.P.3 — Coding the Process Description
The manufacturing process section 3.2.P.3 is the most operationally complex section of the CMC submission to convert to PQ-CMC structured format — because it requires representing not just…
Article
Expression System and Cell Line Development — The 3.2.S.2 Foundation for Biologics
When FDA reviewers open the drug substance section of a BLA for a monoclonal antibody, the first thing they assess is whether the expression system and cell line…
Article
FDA KASA Technical Architecture — How the Knowledge-Aided Assessment Works
FDA's Knowledge-Aided Assessment and Structured Application system — KASA — is the structured, risk-based quality assessment platform that Office of Pharmaceutical Quality reviewers now use in place of…
Article
Organ-Selective LNP Design — SORT Technology, Helper Lipid Screening, and Emerging CMC Implications
Standard LNP drug products deliver to the liver by default — apolipoprotein E adsorbs to the PEGylated particle surface in the bloodstream and mediates hepatocyte uptake through LDLR-mediated…
Article
HL7 FHIR for Pharmaceutical CMC — The Architecture Behind PQ-CMC
Most pharmaceutical CMC professionals know that PQ-CMC requires HL7 FHIR-formatted data — very few understand what FHIR actually is, how it structures pharmaceutical data, and why the data…
Article
LNP Comparability for Post-Approval Manufacturing Changes — ICH Q5E Applied to a Non-Protein Biologic
ICH Q5E was written for protein biologics — it describes comparability in terms of primary structure, higher-order structure, biological activity, and process-related impurities that are specific to recombinant…
Read with purpose
Every analysis should make the next move clearer.
- 01ReadUnderstand the technical argument.
- 02TraceFollow evidence and regulatory context.
- 03CompareExplore related XGene intelligence.
- 04ActConnect the issue to a practical pathway.

